A detailed history of Jessup Wealth Management, Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Jessup Wealth Management, Inc holds 392 shares of LLY stock, worth $341,185. This represents 0.13% of its overall portfolio holdings.

Number of Shares
392
Previous 373 5.09%
Holding current value
$341,185
Previous $331 Million 8.36%
% of portfolio
0.13%
Previous 0.15%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 31, 2025

BUY
$727.2 - $932.06 $13,816 - $17,709
19 Added 5.09%
392 $303 Million
Q3 2024

Oct 09, 2024

SELL
$772.14 - $960.02 $13,126 - $16,320
-17 Reduced 4.36%
373 $331 Million
Q1 2024

Apr 15, 2024

BUY
$592.2 - $792.28 $230,958 - $308,989
390 New
390 $303 Million
Q4 2022

Jan 30, 2023

BUY
$321.55 - $374.67 $4.27 Million - $4.97 Million
13,266 New
13,266 $4.85 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $827B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Jessup Wealth Management, Inc Portfolio

Follow Jessup Wealth Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jessup Wealth Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Jessup Wealth Management, Inc with notifications on news.